Dopaminergic agents for the treatment of cerebral and peripheral blood flow disorders

摘要

The invention deals with the use of N-(aminoacyl)-amino acids of Formula (I), especially anapril, (2 R, 4 R)-2-(2-hydroxy-phenyl)-3-(3- aminopropionyl)-4-thiazolidine carboxylic acid, and 1-[(2 S)-3-amino-4- methyl-propionyl]-2-proline as dopaminergic active ingredients for increasing central or peripheral blood flow disorders.